Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of SeeMore (EVP 1001-1) for Myocardial Viability Assessment
NCT01989195Phase 2Completed
- Sponsor
- Stanford University
- Start
- May 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EVP-1001-1 in ischemic cardiomyopathy (ICM), sponsored by Stanford University. Started May 2013; status: completed.
02
Drugs
EVP-1001-1
03
Conditions
ischemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on NCT01989195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01989195.